109 related articles for article (PubMed ID: 6635966)
41. [Clinico-endoscopic study of the comparative therapeutic effectiveness of cimetidine alone or combined with fentonium bromide in gastric and duodenal ulcer].
Rodrigo Sáez L; Alonso González JL; Cornago Sánchez A; Pérez Alvarez R; Sánchez Lombraña JL; Faedo Presa I
Rev Esp Enferm Apar Dig; 1981 Jan; 59(1):69-78. PubMed ID: 7209100
[No Abstract] [Full Text] [Related]
42. [The effect of "triple therapy" on the eradicating of H. pylori and the healing of a duodenal ulcer. The initial study and 6 months later].
Gisbert JP; Boixeda D; de Rafael L; Martín de Argila C; Bermejo F; García Plaza A
Rev Esp Enferm Dig; 1995 Mar; 87(3):193-8. PubMed ID: 7742047
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the healing capacities of sucralfate and cimetidine in the short-term treatment of duodenal ulcer: a double-blind randomized trial.
Martin F; Farley A; Gagnon M; Bensemana D
Gastroenterology; 1982 Mar; 82(3):401-5. PubMed ID: 6895626
[TBL] [Abstract][Full Text] [Related]
44. Relapse of duodenal ulcers after cimetidine treatment: idol "indecently" assaulted?
Miller JP
Aust N Z J Med; 1986 Apr; 16(2):246. PubMed ID: 3463282
[No Abstract] [Full Text] [Related]
45. Predictors of duodenal ulcer healing and relapse.
Sonnenberg A; Müller-Lissner SA; Vogel E; Schmid P; Gonvers JJ; Peter P; Strohmeyer G; Blum AL
Gastroenterology; 1981 Dec; 81(6):1061-7. PubMed ID: 7026344
[TBL] [Abstract][Full Text] [Related]
46. [Controlled cimetidine treatment of duodenal ulcer compared with the traditional ulcer disease treatment (author's transl)].
Petö S; Petö H
Lijec Vjesn; 1980 Sep; 102(9):517-21. PubMed ID: 7017324
[No Abstract] [Full Text] [Related]
47. Role of protective drugs in the prevention of ulcer relapse.
Ota S; Terano A
J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
[TBL] [Abstract][Full Text] [Related]
48. [Long-term cimetidine therapy dose not change the recurrence frequency of ulcer].
Danø P
Ugeskr Laeger; 1982 Aug; 144(31):2304. PubMed ID: 7147448
[No Abstract] [Full Text] [Related]
49. Long-term treatment of duodenal ulcer with cimetidine. Intermittent or continuous therapy?
Hetzel DJ; Hecker R; Shearman DJ
Med J Aust; 1980 Nov; 2(11):612-4. PubMed ID: 7007840
[TBL] [Abstract][Full Text] [Related]
50. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
Iser JH; Buttigieg RJ; Iseli A
Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009
[TBL] [Abstract][Full Text] [Related]
51. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
[TBL] [Abstract][Full Text] [Related]
52. Helicobacter pylori and refractory duodenal ulcers: cross-over comparison of continued cimetidine with cimetidine plus antimicrobials.
Boyd HK; Zaterka S; Eisig JN; Chinzon D; Iriya K; Laudanna AA; Boyd EJ
Am J Gastroenterol; 1994 Sep; 89(9):1505-10. PubMed ID: 8079928
[TBL] [Abstract][Full Text] [Related]
53. Ulcer healing and serum pepsinogen I in cimetidine and glycopyrrolate treated duodenal ulcer patients.
Pikkarainen P; Vuoristo M; Tarpila S
Ann Clin Res; 1981 Apr; 13(2):81-4. PubMed ID: 7015989
[TBL] [Abstract][Full Text] [Related]
54. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
[TBL] [Abstract][Full Text] [Related]
55. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
Schütze K; Hentschel E
Z Gastroenterol; 1995 Nov; 33(11):651-3. PubMed ID: 8600661
[TBL] [Abstract][Full Text] [Related]
56. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer].
Pal'tsev AI; Maslennikova TA
Ter Arkh; 1997; 69(2):62-3. PubMed ID: 9173582
[No Abstract] [Full Text] [Related]
57. [Clinical and economical efficacy of the different variants of inpatient treatment of ulcerative diseases].
Vakhrushev IaM; Muravtseva OV
Eksp Klin Gastroenterol; 2008; (4):28-30. PubMed ID: 19145900
[TBL] [Abstract][Full Text] [Related]
58. Cimetidine in the treatment of duodenal ulcer.
Misra RC; Gupta BB; Agarwal SK; Gupta PS
J Assoc Physicians India; 1981 Sep; 29(9):705-9. PubMed ID: 7345066
[No Abstract] [Full Text] [Related]
59. [Prolonged cimetidine treatment in duodenal and gastric ulcer. Clinical experience].
Cagianelli MA; Cipriani M; Ceccarelli M; Mioni V; Tognarelli S
Clin Ter; 1981 Sep; 98(5):511-5. PubMed ID: 7307451
[No Abstract] [Full Text] [Related]
60. Pharmacokinetics of cimetidine in patients with unresponsive duodenal ulcer.
Rovati V; Foschi D; Benvenuti C; Alfieri G
Int J Clin Pharmacol Res; 1983; 3(2):71-6. PubMed ID: 6679515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
